CLINICAL_TRIALS
trial_result
· 2025-07-01
Clinical Trial Update: A Study of TAK-861 for the Treatment of Narcolepsy Type 1 [Phase 3]
Summary
The Phase 3 trial of TAK-861 for Narcolepsy Type 1 has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Narcolepsy Type 1 | Phase 3 | Status: COMPLETED